Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2009
Total Assets: $1.62B
Liabilities Breakdown FY2009
Total Liabilities: $457.6M
Asset Breakdown
Total Assets: $1.62B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $334.1M | 20.7% |
| Accounts Receivable | $249.4M | 15.4% |
| Inventory | $165.9M | 10.3% |
| Property, Plant & Equipment | $252.0M | 15.6% |
| Goodwill | $315.2M | 19.5% |
| Intangible Assets | $86.7M | 5.4% |
| Other Assets | $212.2M | 13.1% |
Liabilities Breakdown
Total Liabilities: $457.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $51.1M | 11.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $406.5M | 88.8% |